- Filed
- Feb 21, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Feb 14, 2025 | 385.82M sh |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $3.02B |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $4.57B |
| Current Assets | FY 2024 · Dec 31, 2023 | $10.33B |
| Total Assets | FY 2024 · Dec 31, 2023 | $18.43B |
| Shares Diluted | FY 2024 · Dec 31, 2022 | 416M sh |
| Stock Repurchased | FY 2024 · Dec 31, 2022 | $3.33B |
| Capex | FY 2024 · Dec 31, 2022 | $400M |
| Operating Cash Flow | FY 2024 · Dec 31, 2022 | $4.98B |
| Cash And Equivalents | FY 2024 · Dec 31, 2022 | $3.21B |
| Eps Diluted | FY 2024 · Dec 31, 2022 | $20.12 |
| Eps Basic | FY 2024 · Dec 31, 2022 | $21.26 |
| Sga Expense | FY 2024 · Dec 31, 2022 | $1.13B |
| Rd Expense | FY 2024 · Dec 31, 2022 | $3.3B |
| Net Income | FY 2024 · Dec 31, 2022 | $8.36B |
| Operating Income | FY 2024 · Dec 31, 2022 | $9.42B |
| Cost Of Revenue | FY 2024 · Dec 31, 2022 | $5.42B |
| Revenue | FY 2024 · Dec 31, 2022 | $19.26B |
| Stockholders Equity | FY 2024 · Dec 31, 2021 | $14.15B |